U.S. Markets closed

FSD Pharma Secures Sales License for Massive Production Facility -- CFN Media

Newsfile Corp.

Seattle, Washington--(Newsfile Corp. - April 23, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9). The company became the latest licensed producer to possess both cultivation and sales licenses on April 22 after securing its cannabis sales license from Health Canada. With nearly four million sq. ft. of space in a former Kraft Foods plant in Cobourg, Ontario, the company is uniquely positioned to scale up and become one of the largest licensed producers in the country over the coming quarters.

Canada's cannabis industry has experienced tremendous growth over the past several years, following the legalization of medical and adult-use cannabis. In addition to growing domestic demand, the country's move to federally regulate cannabis has opened the door for its licensed producers to export products around the world. These dynamics have made licensed producers a valuable addition to growth investment portfolios.

Securing a Sales License

FSD Pharma has spent the past several years retrofitting a nearly four million sq. ft. former Kraft Foods facility that sits on 70 acres of land-including 40 acres primed for development. After securing its cultivation license on October 13, 2017, the company was awarded a cannabis sales license on April 22, 2019 by Health Canada. The move paves the way for the company to produce and sell cannabis grown at its facility.

The company's business model hinges on strategic partnerships that operate within its massive facility. For example, the company's partnership with Canntab Therapeutics Ltd. provides 10,000 sq. ft. of space at its facility in exchange for a profit-sharing and royalty agreement. Canntab's proprietary technology enables standardized medical cannabis extracts in extended release pill formats that are ideal for physicians.

"The granting of our sales license allows FSD to serve the growing medicinal use markets in Canada," said FSD Pharma President Zeeshan Saeed. "We intend to quickly scale up production at our current facility, while continuing to build out the plant to add additional grow capacity. In addition, our sales license opens the door for our partner Canntab Therapeutics to commence sales of its suite of novel cannabis oral delivery platforms."

Near-term & Long-term Potential

FSD Pharma's new cannabis sales license creates a near-term revenue opportunity for shareholders. Under its partnership with Canntab and others, the company is entitled to a share of revenue that could begin in the very near-term. The company's wide range of strategic partnerships could help diversify revenue and limit capital expenditures compared to many other licensed producers that invest in their own equipment and operations.

In addition to this near-term potential, the company has made a number of blue sky investments in the cannabis industry. A great example is the company's recent letter of intent with Solarvest to develop and test a way to create pharmaceutical-grade cannabinoids out of algae. If successful, this approach could dramatically increase production capacity without nearly as much overhead as conventional growing operations.

The company also announced an entry into the lucrative hemp industry with a 3-way supply agreement to purchase up to 1,000 kilograms of hemp crop for CBD extraction. The deal could open the door to hemp-based CBD products that can be more widely distributed across numerous different countries that haven't legalized medical or recreational cannabis, including parts of the United States and Europe.

Looking Ahead

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) reached a critical milestone by securing a cannabis sales license. With the potential for near-term revenue, investors may want to take a closer look at the stock over the coming months. At the same time, the company's long-term investments could prove game-changers in the rapidly evolving industry.

For more information, visit the company's website at www.fsdpharma.com.

Please follow the link to read the full article on CFN:

https://www.cannabisfn.com/fsd-pharma-secures-sales-license-for-massive-production-facility/

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided onhttp://www.cannabisfn.com (the 'Site') is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Contact:

Frank Lane
206-369-7050
Flane@cannabisfn.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/44229